We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Summit Therapeutics Plc | LSE:SUMM | London | Ordinary Share | GB00BN40HZ01 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 20.50 | 18.00 | 23.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMSUMM
RNS Number : 7948D
AIM
24 February 2020
NOTICE
24/02/2020
NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON
At the request of the Company the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.
Hot Features
Premium
SUMMIT THERAPEUTICS PLC
213800NRW8AOMYMTBD89
ORDINARY SHARES (BN40HZ0)(GB00BN40HZ01) SUMT THER/PAR VTG FDP 0.01
OF 1P EACH, FULLY
PAID
----------------------- --------------------------
If you have any queries or require further information, please contact the company's nominated adviser +44 (0)20 7213 0880.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
AMOUASVRRRUUUAR
(END) Dow Jones Newswires
February 24, 2020 02:00 ET (07:00 GMT)
1 Year Summit Therapeutics Chart |
1 Month Summit Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
